3.1. Patient characteristics
TNBC, neurotoxic, cancer therapy-neurotoxicity
TRIPLE NEGATIVE BREAST CANCER, RECURRENT BREAST CANCER
Of the 44 patients enrolled in the previous randomized trial, 38 patients met the eligibility criteria. Six patients were exempted from this survey due to the following reasons: having neurotoxic therapy for advanced or recurrent breast cancer,Clinicopathological factors.FACT-NTx = functional assessment of cancer therapy-neurotoxicity, SD = standard deviation, TNBC = triple negative breast cancer.Factors were compared by treatment groups using Fisher exact test for categorical variables and Consort diagram for this survey.